Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
J690DHTxEdLFzZW5
